Cite
Mehta G, Rousell S, Burgess G, et al. A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis. J Clin Exp Hepatol. 2017;8(3):224-234doi: 10.1016/j.jceh.2017.11.006.
Mehta, G., Rousell, S., Burgess, G., Morris, M., Wright, G., McPherson, S., Frenette, C., Cave, M., Hagerty, D. T., Spada, A., & Jalan, R. (2018). A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis. Journal of clinical and experimental hepatology, 8(3), 224-234. https://doi.org/10.1016/j.jceh.2017.11.006
Mehta, Gautam, et al. "A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis." Journal of clinical and experimental hepatology vol. 8,3 (2018): 224-234. doi: https://doi.org/10.1016/j.jceh.2017.11.006
Mehta G, Rousell S, Burgess G, Morris M, Wright G, McPherson S, Frenette C, Cave M, Hagerty DT, Spada A, Jalan R. A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis. J Clin Exp Hepatol. 2018 Sep;8(3):224-234. doi: 10.1016/j.jceh.2017.11.006. Epub 2017 Nov 22. PMID: 30302038; PMCID: PMC6175779.
Copy
Download .nbib